![]() | David H KesselShow email addressDepartment of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. | Department of Pharmacology, Wayne State University School of Medicine, Detroit ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
David H Kessel:Expert Impact
Concepts for whichDavid H Kesselhas direct influence:Photodynamic therapy,Apoptotic response,Lysosomal photodamage,L1210 cells,Plasma lipoproteins,Ursodeoxycholic acid,Mitochondrial photodamage,Leukemia l1210.
David H Kessel:KOL impact
Concepts related to the work of other authors for whichfor which David H Kessel has influence:Photodynamic therapy,Cell death,Singlet oxygen,Autophagic flux,Oxidative stress,Breast cancer,Photosensitizing agents.
KOL Resume for David H Kessel
Year | |
---|---|
2022 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. |
2021 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA |
2020 | Wayne State Univ. School of Medicine (United States) Department of Pharmacology, School of Medicine. |
2019 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. |
2018 | Wayne State University School of Medicine Detroit MI |
2017 | Department of Pharmacology Wayne State University School of Medicine Detroit MI |
2016 | Wayne State University Department of Pharmacology Detroit MI |
2015 | Department of Pharmacology, Wayne State University School of Medicine, 48201, Detroit, MI, USA |
2013 | Cancer Biology program Wayne State University School of Medicine Detroit MI |
2012 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201 (USA) phone: +001 313 577 1787 Wayne State Univ. (USA) |
2011 | Department of Pharmacology, Wayne State University School of Medicine, 540 East Canfield Street, Detroit, MI 48201. |
2010 | Wayne State University School of Medicine, Cancer Biology Program and Department of Pharmacology, Detroit, Michigan, 48201 |
2009 | Departments of Pharmacology and Medicine, Wayne State University School of Medicine, Detroit, MI |
2007 | Department of Pharmacology and Medicine, Wayne State University, School of Medicine, Detroit, MI David Kessel |
2006 | Departments of Pharmacology and Medicine, Wayne State University, Detroit, MI 48201, USA Department of Pharmacology, WSU School of Medicine, 540, E. Canfield St., Detroit MI 48201. |
2005 | Department of Pharmacology, Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI 48201, USA |
2004 | Department of Pharmacology, Wayne State University School of Medicine, 540 E Canfield Street, Detroit, MI 48201, USA |
2003 | Wayne State Univ. School of Medicine (USA) |
2002 | Department of Pharmacology, Wayne State University School of Medicine, Detroit MI 48201, USA. |
2001 | WSU School of Medicine, Detroit, MI, USA |
2000 | Wayne State University Pharmacology Department, Detroit, Michigan, USA |
1999 | Department of Pharmacology, Wayne State University School of Medicine, 48201, Detroit, Michigan, USA |
1998 | Department of Pharmacology, Wayne State University, School of Medicine, Detroit, Ml, USA |
1997 | Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA |
1996 | Department of Pharmacology, Wayne State University School of Medicine, 540 E. Canfield Street, Detroit, Michigan, 48201 Wayne State University, School of Medicine, Detroit, MI, USA |
1995 | Department of Pharmacology, Wayne State University School of Medicine, 48201, Detroit, Michigan |
1994 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201 |
1993 | Departments of Pharmacology and Medicine, Wayne State University School of Medicine, Detroit, MI 48201 USA |
1992 | b Michigan Cancer Foundation and Department of Pharmacology , Division of Hematology/Oncology, Wayne State University School of Medicine , P.O. Box 02188, Detroit , MI , 48202 , U.S.A. Wayne State University, Detroit, MI, USA |
1991 | Department of Pharmacology, Wayne State University, Detroit, Michigan 48201. |
1990 | Department of Pharmacology, Wayne State University School of Medicine, 48201, Detroit, Mi, USA |
1989 | Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201. Wayne State University (United States) |
1988 | Harper Hospital Detroit, MI 48201 USA Wayne State University, School of Medicine, Detroit, MI 48201 U.S.A. |
1987 | Departments of Medicine and Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA Wayne State University School of Medicine and Harper Hospital (United States) |
Concept | World rank |
---|---|
cells porphycene concentrations | #1 |
interferometry characterization | #1 |
photosensitizing agents distribution | #1 |
nonpeptidic bcl2 ligand | #1 |
cell fragmentation cells | #1 |
e6 product | #1 |
ethanol delivery systems | #1 |
form herbicide analog | #1 |
monomeric hpd components | #1 |
experimental approaches elucidation | #1 |
lysyl analogs | #1 |
snet2h2 | #1 |
3p aminophenyl fluorescein | #1 |
porphyrin preparation | #1 |
sequential protocol photofrin | #1 |
chloro enamines ynamines | #1 |
iron complex presence | #1 |
cremophor concentrations cmc | #1 |
subsequent division cells | #1 |
parpcleavage assay | #1 |
shutdown tumor vasculature | #1 |
contrast dadpo | #1 |
murine leukemia cells | #1 |
bcl2 photodamage target | #1 |
experimental adr | #1 |
vivo effectiveness compounds | #1 |
apoptosis subcellular sites | #1 |
purpurins nt2 | #1 |
spectrometry hpd | #1 |
cpo rapid activation | #1 |
camptothecin formation | #1 |
cremophor drug formulation | #1 |
oligomeric hematoporphyrin | #1 |
autophagy lethal consequences | #1 |
vinblastine daunorubicin accumulation | #1 |
effects photodynamic therapy | #1 |
insertion polarizers | #1 |
extensive lysosomal photodamage | #1 |
paraptosis efficacy | #1 |
dimer oligomer fraction | #1 |
photodamaged lysosomes | #1 |
hematoporphyrin‐derived | #1 |
detroit inhibitor | #1 |
cmc p388 | #1 |
wavelength pathway | #1 |
hematoporphyrin residues | #1 |
agent cell types | #1 |
mitochondria lysosomes initiates | #1 |
apoptotic effects photodamage | #1 |
cell lysis presence | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by David H Kessel
Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage
[ PUBLICATION ]
Photodynamic therapy (PDT) protocols employing lysosomal sensitizers induce apoptosis via a mechanism that causes cytochrome c release prior to loss of mitochondrial membrane potential (ΔΨm). The current study was designed to determine how lysosomal photodamage initiates mitochondrial-mediated apoptosis in murine hepatoma 1c1c7 cells. Fluorescence microscopy demonstrated that the photosensitizer N-aspartyl chlorin e6 (NPe6) localized to the lysosomes. Irradiation of cultures preloaded ...
Known for Bid Cleavage | Release Cytochrome | Lysosomal Photodamage | 8 Caspase | Fluorescence Microscopy |
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
[ PUBLICATION ]
Research in autophagy continues to accelerate,(1) and as a result many new scientists are entering the field. Accordingly, it is important to establish a standard set of criteria for monitoring macroautophagy in different organisms. Recent reviews have described the range of assays that have been used for this purpose.(2,3) There are many useful and convenient methods that can be used to monitor macroautophagy in yeast, but relatively few in other model systems, and there is much ...
Known for Higher Eukaryotes | Interpretation Assays | Monitoring Autophagy | Model Systems | Key Point |
Monitoring Singlet Oxygen and Hydroxyl Radical Formation with Fluorescent Probes During Photodynamic Therapy
[ PUBLICATION ]
Singlet oxygen (1O2) is the primary oxidant generated in photodynamic therapy (PDT) protocols involving sensitizers resulting in type II reactions. 1O2 can give rise to additional reactive oxygen species (ROS) such as the hydroxyl radical (*OH). The current study was designed to assess 3'-p-(aminophenyl) fluorescein (APF) and 3'-p-(hydroxyphenyl) fluorescein (HPF) as probes for the detection of 1O2 and *OH under conditions relevant to PDT. Cell-free studies indicated that both APF and ...
Known for Hydroxyl Radical | Singlet Oxygen | Photodynamic Therapy | Formation Ros | Fluorescent Probes |
Photodynamic therapy (PDT) involves photosensitizing agents that, in the presence of oxygen and light, initiate formation of cytotoxic reactive oxygen species (ROS). PDT commonly induces both apoptosis and autophagy. Previous studies with murine hepatoma 1c1c7 cells indicated that loss of autophagy-related protein 7 (ATG7) inhibited autophagy and enhanced the cytotoxicity of photosensitizers that mediate photodamage to mitochondria or the endoplasmic reticulum. In this study, we examined ...
Known for Cell Death | Lysosomal Photodamage | Photosensitizing Agents | Pdt Apoptosis | Autophagy Protein |
Irradiation of murine hepatoma 1c1c7 cultures presensitized with N-aspartyl chlorin e6 (NPe6) caused lysosomal disruption and apoptosis. Tao cells, a variant of the 1c1c7 line having lower aryl hydrocarbon receptor (AhR) contents, were resistant to the pro-apoptotic effects of NPe6 in the same photodynamic therapy protocol. Colony-forming assays were used to establish light dose-dependent and NPe6 concentration-dependent cytotoxicity curves. Lysosomal breakage and cell survival ...
Known for Aryl Hydrocarbon | Murine Hepatoma | Tao Cells | Lysosomal Photosensitizer | Cell Lines |
BACKGROUND AND OBJECTIVES: This study was designed to examine modes of cell death after photodynamic therapy (PDT).
STUDY DESIGN: Murine leukemia L1210 cells and human prostate Bax-deficient DU145 cells were examined after PDT-induced photodamage to the endoplasmic reticulum (ER). Phase contrast, fluorescence and electron microscopy were used to identify changes in cellular morphology, chromatin condensation, loss of mitochondrial membrane potential, and formation of phagolysosomes. ...
Known for Photodynamic Therapy | Pdt Apoptosis | Electron Microscopy | Autophagy Blotting | Cell Death |
Photodynamic therapy (PDT) can cause lethal photodamage by both direct and indirect mechanisms. Direct modes of cell death relate to nonspecific necrosis and the initiation of signaling pathways that elicit apoptosis, autophagy or both. In this report, effects of low-dose and high-dose PDT are explored, comparing sensitizers that localize in the endoplasmic reticulum (the porphycene termed CPO) or mitochondria (mesochlorin). To explore the role of autophagy, two cell lines were ...
Known for Endoplasmic Reticulum | Pdt Dose | Apoptosis Autophagy | Cell Lines | Bcl2 Protein |
Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent
[ PUBLICATION ]
OBJECTIVE: A relatively low level of lysosomal photodamage has been shown capable of promoting the efficacy of photodamage simultaneously or subsequently directed to mitochondrial/ER sites. The procedure has hitherto involved the use of two photosensitizing agents that require irradiation at two different wavelengths and different formulation techniques. This, together with different pharmacokinetic profiles of the photosensitizers, adds a layer of complexity to a protocol that we have ...
Known for Photodynamic Therapy | Liposomal Formulation | Lysosomes Mitochondria | Photosensitizing Agents | Lysosomal Photodamage |
The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80
[ PUBLICATION ]
The phenoxypropionic acid derivative 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469) and an analogue termed 2-{4-[(7-bromo-2-quinalinyl)oxy]phenoxy}propionic acid (SH80) can eradicate malignant cell types resistant to many common antitumor agents. Colony formation assays indicated that a 24 h exposure of L1210 cells to XK469 or SH80 inhibited clonogenic growth with CI(90) values of 10 and 13 micromol/L, respectively. This effect was associated with G(2)-M arrest and the ...
Known for Cells Xk469 | Apoptosis Autophagy | Cell Cycle | Acid Sh80 | Antineoplastic Agents |
The photosensitizer 9-capronyloxytetrakis (methoxyethyl) porphycene localizes predominantly in the endoplasmic reticulum (ER) and, to a lesser extent, in mitochondria of murine leukemia L1210 cells. Subsequent irradiation results in the loss of ER > mitochondrial Bcl-2 and an apoptotic response. Although an increase in cytosolic Ca2+ was observed after irradiation, apoptosis was not inhibited by either the presence of the calcium chelator BAPTA or by the mitochondrial uniporter inhibitor ...
Known for Endoplasmic Reticulum | Reactive Oxygen | Mitochondrial Ca2 | Photodynamic Therapy | Loss Bcl2 |
Photodynamic therapy (PDT) of neoplastic cell lines is sometimes associated with the rapid initiation of apoptosis, a mode of cell death that results in a distinct pattern of cellular and DNA fragmentation. The apoptotic response appears to be a function of both the sensitizer and the cell line. In this study, we examined photodynamic effects of several photosensitizers on murine leukemia P388 cells. Two drugs, a porphycene dimer (PcD) and tin etiopurpurin (SnET2), which localized at ...
Known for Photodynamic Therapy | Rapid Initiation | Pdt Doses | Apoptosis Dna | Cell Death |
Apoptosis is a cellular death process involving the sequential activation of a series of caspases, endonucleases, and other enzymes. The initiation of apoptosis can be inhibited by overexpression of bcl-2 and certain other members of a related family of proteins. We examined the effects of bcl-2 overexpression on the apoptotic response to photodynamic therapy (PDT), using aluminum phthalocyanine as the photosensitizing agent. In this study, we compared the immortalized human breast ...
Known for Apoptotic Response | Photodynamic Therapy | Bax Pdt | Proteins Bcl2 | Photosensitizing Agent |